Effect of Navkarshika ghana vati (a classical ayurvedic medicine) in Gout (Vatarakta)

A clinical study on the management of vatarakta w.s.r to Gout with Navkarshika ghana vati

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/02/017862

Enrollment

Registered

2019-02-28

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

Intervention1: Classical Ayurvedic medicine Navkarshika ghana vati 2 tablets of 500mg, 4 times a day after food with luke warm water for 2 months: This classical medicine is explained in Chakradatta,

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Pratyatma Lakshanas(Cardinal features) of Vatarakta & also with symptoms of Gout, fulfilling the diagnostic criteria of ACR Guidelines will be included in the present clinical trial.

Exclusion criteria

Exclusion criteria: Patient of Vatarakta associated with any systemic disorder such as Diabetes, Hpertension. Patient with any other severe arthritis condition (such as Rheumatoid arthritis, Septic arthritis ) will be excluded from study

Design outcomes

Primary

Measure	Time frame
Effect of treatment on uric acid levelsTimepoint: done at baseline and end of study (2 months)	—

Secondary

Measure	Time frame
Effect of treatment on symptoms like sandhi shotha (joint inflammation), sandhi shoola ( joint pain), daha (burning sensation), twak vivarnata( skin discoloration), suptatha (numbness)Timepoint: done at baseline and at each follow at interval of 15 days till the end of 2 months	—

Countries

India

Contacts

Public ContactDr Shivangi Choube

Parul Institute of Ayurved

drshivangi1989@gmail.com9981411478

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026